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Evaluating Methods of Obtaining Male Pheromone from Hymenochirus Sp. Using Analytical
Chemistry

Abstract

By Vincent Wing-Kun Leung
University of the Pacific
2019

Male Hymenochirus sp. frogs are known to release pheromone that attracts females of the
same species. Four methods for collecting secretions containing pheromone in Hymenochirus
sp. were tested: norepinephrine injection, gonadotropin-releasing hormone injection,
homogenization of gland tissue, and electrostimulation of the skin over the breeding gland area.
The samples collected were analyzed using high-performance liquid chromatography (HPLC)
and mass spectrometry. The HPLC chromatograph for the male norepinephrine sample
contained a peak at 6.4 min that was not in the female norepinephrine sample HPLC
chromatograph. The male norepinephrine sample mass spectrum had a peak of m/z 292.0 not in
the female norepinephrine sample mass spectrum. Breeding gland homogenate mass spectra
showed major peaks with m/z values of 203.9, 245.2, 484.8, and 558.9. The male
norepinephrine sample mass spectrum contained peaks with the same m/z values, but the female
norepinephrine sample did not. Serotonin and a novel truncated hymenochirin were found in
male and female samples collected using norepinephrine or GnRH injection. HPLC results
showed that electrostimulation of male frogs, as performed in this study, did not cause secretion
of as many chemical compounds as the other methods. Electrical stimulation was done with a
voltage of 0.75 V and stainless steel electrodes, instead of the 4.1 V and platinum electrodes used
in other studies. The current produced was likely insufficient to stimulate the breeding gland.
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Behavioral testing was conducted testing female attraction to males injected with GnRH, and
certain HPLC fractions of the male norepinephrine and breeding gland homogenate samples. No
attraction was found to any of the tested stimuli. HPLC chromatograph and mass spectrum
differences between the male and female norepinephrine-induced samples suggested a
pheromone could be present. However, without a behavioral trial result showing female
attraction to a collected sample, the presence of a pheromone was not definitively proven.
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Chapter 1: Introduction
Male frogs (Order Anura) most commonly use acoustic communication to attract
conspecific females and to denote their territory to other males [1]. Species in which male frogs
lack vocal sacs in the genus Rana (Family Ranidae) are known to have modified mucosal glands
that histologically resemble glands in salamanders that secrete pheromone [2], suggesting that
pheromone release may replace acoustic signals in male attraction of females. Female-attracting
peptide pheromones have been found in some species of salamander, and also in frogs, the first
being in the magnificent tree frog, Litoria splendida [3].
In the frog Xenopus laevis, males have glands on their thumbs and forearms that grow in
size during the mating season, together forming a nuptial pad [4]. These glands may play a role
in male courtship of females. A histological survey of sexually dimorphic skin glands in frogs
other than Xenopus found that most of the glands resembled the Xenopus nuptial pads in
structure, in their secretory granules in gland cells, and in their staining, positive for neutral
mucopeptides and negative for acidic mucopeptides [5]. In Rana pipiens, glands on the thumbs
of males grow during the mating season and accumulate secretory granules, also suggesting a
gland with a female-attracting role [6].
In the frog genus Rana, a histological survey of five species by the Brizzi lab showed that
males of two Rana species lacking vocal sacs have specialized glands on the dorsal skin, with
cells resembling those of mucosal glands, containing dense secretory granules [2]. It also
showed that the three species of Rana with vocal sacs did not have these specialized glands.
These glands were found to lack direct innervation, similar to the mucosal glands of frogs and
unlike the breeding glands in salamanders, indicating that these glands are modified mucosal
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glands. Brizzi et al. (2002) [2] wrote in their paper that the findings confirm the existence of
glands in Rana similar to the breeding glands described by Thomas et al. [5].
Antimicrobial Peptides
In plants, insects, frogs, and mammals, antimicrobial peptides act in various ways to kill
bacteria, fungi, and enveloped viruses [7]. Many antimicrobial peptides in frogs have a cationic
amphipathic alpha-helix secondary structure: the helix is formed by predominately nonpolar
amino acids for 180°, followed by positive residues for 180°; this pattern repeats for the length of
the peptide. This amphipathic structure allows the helix to interact with cell membranes [8].
Previous research using nuclear magnetic resonance (NMR) spectrometry has shown that antimicrobial peptides form a toroid pore, with the cationic (positively-charged) side of the peptides
contacting the negatively-charged membrane phospholipids. The cell contents can then leak out
of the pore, presumably leading to the microbe’s death [9]. Efficacy of antimicrobial peptides is
determined by a complex interaction of cationicity of the protein, hydrophobicity, stability of the
α-helix, and degree of amphipathicity [8].
Antimicrobial peptides made in mucosal glands have been theorized to evolve into
peptides with other functions, to explain reduced antimicrobial activity. Conlon et al. (2012)
wrote that in Silurana and Xenopus, octoploid species were found to have the same number of
antimicrobial peptides as tetraploid species, with conserved secondary structure, except for X.
amieti, whose skin contains the PGLa-AM2 peptide that had low anti-microbial activity and
reduced cationicity [10]. They theorized that the peptide underwent “neofunctionalization” and
has acquired a new function after losing its original function. Another term for a pre-existing
feature being repurposed for another function is exaptation.
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Hymenochirins
Skin peptides in Hymenochirus frogs have been previously studied by Mecharska and
associated (2012) for anti-microbial properties [11]. Each animal was injected with
norepinephrine hydrochloride (40 nmol/g body weight), and put in 40 mL of distilled water for
15 min to collect secretions. One mL of trifluoroacetic acid (TFA) was added before freezing.
The sample was passed through 4 Sep-Pak C-18 cartridges and eluted with
acetonitrile/water/TFA (70.0:29.9:0.1 v/v/v) and lyophilized. It was reconstituted in water with
0.1% TFA, and run on a Vydac C-18 HPLC column. The peptides they found were categorized
into a family of host-defense peptides called hymenochirins. Five hymenochirins were initially
found, which were subsequently named hymenochirins 1B-5B. The molecular masses of the five
hymenochirins were found using mass spectrometry and sequenced by Edman degradation. All
five peptides were found to have fairly low minimum inhibitory concentrations (MIC) in
antimicrobial assays. Therefore, hymenochirins 1B-5B are good inhibitors of microbial growth,
and have not lost their functionality.
The Mechkarska article presented HPLC plots, with peaks labeled with numbers 1-5.
These numbers correspond to hymenochirins 1B-5B, which have very similar hydrophobicity
values. Using the hydrophobicity values calculated by Meek [12] for HPLC at a pH of 2.1, and
normalizing to a scale from 0 to 1, the average hydrophobicities of hymenochirins 1B-5B are
0.364, 0.400, 0.369, 0.384, and 0.405, respectively. These values are very close to each other,
and the order in which the hymenochirins eluted are not correlated to the calculated
hydrophobicities. The order of elution may be random, or other factors are involved in the
hymenochirins eluting from the HPLC column.
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The Matthijs research group made an mRNA library from breeding gland of
Hymenochirus boettigeri and predicted sequences for other hymenochirins, based on BLAST
similarity to previous hymenochirins [13]. These are predicted hymenochirins, not actually
observed ones. They observed that the amino acid sequences of the hymenochirins have “low
sequence variation” compared to antimicrobial peptides in Xenopus and Silurana.
Previously Discovered Amphibian Pheromones
The first pheromone discovered in frogs was in Litoria splendida (Family Hylidae),
termed splendiferin [14]. It is a 25 amino acid peptide, with distributed hydrophobic residues,
and two positive and two negative residues. When the splendiferin peptide was applied to a
gauze pad on one end of a tank, females moved towards the pad and sat near the pad.
Pheromones have been previously found in non-frog amphibians as well, in a newt and in
salamanders. The Kikuyama lab had previously discovered a female-attracting pheromone in the
newt Cynops pyrrhogaster [15]. It was named sodefrin, and it was a 10 amino acid peptide.
Three pheromones have been isolated from the mental glands of male Plethodon shermani
salamanders; and amino acid sequences of the pheromone isoforms were found, using gene data
obtained from cDNA libraries. Plethodontid receptivity factor (PRF) shortens the duration of
mating when applied to females, which was interpreted to show that PRF increased female
receptivity [16]. The amino acid sequence of PRF was similar to that of peptides in the
interleukin-6 cytokine family. Plethodontid modulating factor (PMF) lengthened duration of
courtship when applied to females, which was interpreted as PMF decreasing female receptivity
[17]. Twenty-seven plethodontid salamander species were surveyed for RNA encoding for PMF,
using male mental glands, and RNA encoding for PMF was found in all of the plethodontid
species [18]. Sodefrin precursor-like factor (SPF) was found in the mental glands of
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Desmognathus ocoee salamander males, and when applied to females, SPF shortened the time
before insemination, which was interpreted as SPF increasing female receptivity [19]. SPF had a
very similar genetic sequence to the precursor of the sodefrin pheromone previously found in
Cynops pyrrhogaster [19]. SPF was present throughout the plethodontid family [20].
Previous Behavioral Research in Hymenochirus
Frogs of the genus Hymenochirus (African Dwarf Frog, in family Pipidae) are aquatic,
with no tongue or vocal chords. They have bony rods in their larynx to make sound, and males
call to attract females [21]. The presence of a female-attracting pheromone made by males in
Hymenochirus sp. has been found by behavioral study in the Thomas lab, showing female frogs’
preference to move towards water that contained a male frog [22]. The female frogs were put in
a y-shaped maze, the two arms of the maze receiving water dripping from cups above the maze.
The female was free to choose its position in the maze. Females were attracted to water coming
from male frogs with intact breeding gland, and not to water from gland-ablated male frogs.
They were also attracted to water containing homogenatized breeding gland, indicating the
breeding gland to be the source of the mate attractant pheromone. A previous study into
Hymenochirus sp. frogs looked for a potential pheromone using GnRH injection [23]. The study
found the male HPLC chromatograph to have a peak at the retention time of 26.8 min, and the
peak was not in the female chromatograph. The peak was analyzed using tandem mass
spectrometry and behavioral testing showed the HPLC fraction did attract females in a maze.
Secretion-Stimulating Techniques
There are two methods of stimulating skin peptide secretion in frogs previously used by
various labs: injecting the neurotransmitter norepinephrine [24] and electrical stimulation of the
gland [25]. Pearl et al. [22] found a method of stimulating the release of a pheromone from the
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dwarf African clawed frog Hymenochirus sp. by injecting gonadotropin-releasing hormone
(GnRH).
Norepinephrine, in vertebrates, is a stimulatory neurotransmitter of the sympathetic
nervous system (SNS). The SNS regulates gland secretion, and norepinephrine can signal glands
to secrete via the SNS. King, Mechkarska, and Rollins-Smith have used norepinephrine
injection to successfully collect antimicrobial peptides from the mountain chicken frog
Leptodactylus fallax) [26], from Xenopus sp. [27], and from Hymenochirus boettgeri (Family
Pipidae) [11]. The research in Hymenochirus was the first characterization of the hymenochirin
family of peptides.
Electric stimulation has been used on skin granular glands to induce secretion. The
secretion seems to be caused by intrinsic cutaneous muscle contraction [25]. Groups who use
electrical stimulation of skin to induce peptide secretion have found peptides other than
antimicrobial peptides, such as peptides with insulin releasing activity [28], as well as protease
inhibitors, neurotoxins, growth factors, and peptides inducing smooth muscle contraction [29,
30]. Generally, they have used voltages from 3-6 V. None of the studies reported the amount of
current produced by the stimulation pulses. The Chen group has found that they can create an
mRNA library from electrically-stimulated skin secretions, from either the dorsal skin [31] or
from areas of high venom gland concentration [32], which they termed the “granular gland
transcriptome.”
The neuropeptide GnRH has also been used to stimulate skin glands. Vahamaki and
Thomas (1997) demonstrated that GnRH stimulation induced hypertrophy and hyperemia in
breeding glands of Hymenochirus [33]. Pearl et al. stimulated pheromone secretion in male
Hymenochirus using GnRH [22]. GnRH-stimulated breeding gland-ablated males fail to attract
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females, indicating that GnRH enhanced male attractiveness by stimulating breeding gland
secretion. There are multiple possible mechanisms through which GnRH causes breeding gland
secretion. Three possibilities are: firstly, GnRH stimulates the neurons innervating the gland;
secondly, GnRH acts through the pituitary-gonadal axis and causes testosterone or other
hormones from the testes to stimulate secretion of the breeding gland; and thirdly, that GnRH or
a hormone from the testes influenced by GnRH levels activates behavioral centers in the brain
related to courtship, and these centers then stimulate the gland.
The first possibility, that GnRH stimulates neurons innervating the gland, is supported by
research showing that GnRH can cause a late slow excitatory post-synaptic potential (EPSP) in
sympathetic ganglia of bullfrogs, lasting 5-10 min [34]. An EPSP makes neurons more likely to
fire, and EPSP's can sum together to cause an action potential. In this model of gland simulation,
GnRH acts as a neurotransmitter to activate sympathetic ganglia in the frog. The second
possibility, that gonadal hormones mediate gland secretion, could be tested using inhibitors of
androgens. The third possibility, that hormones activate behavior centers can be investigated by
monitoring brain activity in the brain area involved in courtship.
Gland Homogenate
Previous work by Pearl and colleagues (2000) revealed that breeding gland homogenate
could attract females to one side of a maze [22]. This result indicates that a pheromone should
be present in the gland homogenate, and can be found using analytical chemistry techniques
including high-performance liquid chromatography and mass spectrometry. The analytical
chemistry results can be compared to samples obtained from different stimulation methods to
find the pheromone.
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Analytical Chemistry Methods
High-performance liquid chromatography (HPLC). Reverse-phase high performance
liquid chromatography (RP-HPLC) is a technique used to separate molecules by hydrophobicity.
An HPLC column contains silica particles conjugated to molecules with hydrophobic sidechains, such as C-18 (18 carbon-long hydrocarbon) for short peptides. A sample is pumped by
the HPLC instrument onto the column, and a mobile phase more polar than the side-chains of the
column flows through the column. In reverse-phase chromatography, the mobile phase starts
with a high proportion of water. More polar molecules elute first off the column. Then, as the
eluting solvent becomes more nonpolar, nonpolar molecules start eluting off the column. An ion
pairing agents, trifluoroacetic acid (TFA) is added to the solvents to ion-pair the charged amino
acid residues in the sample, causing compounds to elute more selectively at a specific ratio of the
two solvents, creating a sharper peak. The solvent coming out of the column is measured by a
dual-wavelength UV detector, set to measure absorbance at the wavelengths of 200 nm and 280
nm. The lower wavelength, 200 nm, is associated with a peptide bond, which absorbs maximally
between 190 and 230 nm [35]. The higher wavelength, 280 nm, is commonly used to detect
aromatic amino acids in work involving peptides [36].
Mass spectrometry. Mass spectrometry is used to determine the molecular makeup of a
sample. Mass spectrometry measures the mass-to-charge (m/z) ratio of the ionized form of
molecules, and from these data the identities of the molecules present can be elucidated.
The mass spectrometry process occurring inside the mass spectrometer involves
ionization of a sample (i.e. imparting a charge to the sample molecules), acceleration with an
electric (or magnetic) field, and measurement of the degree by which ions are accelerated.
Acceleration depends on both mass (larger molecules are accelerated less) and charge (molecules
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with more charge are affected by the field more, and are accelerated more). The instrument
returns mass-to-charge ratios for the ions that reach the detector. There may be multiple
expected charges for a particular molecule, with some charge values predominating.
Tandem mass spectrometry. Tandem mass spectrometry can be used to find the amino
acid sequence of proteins. It involves selecting a charged molecule with a particular m/z ratio
value, fragmentation of that charged molecular by a fragmentation method, such as collisioninduced dissociation (CID), and detecting the masses of generated fragments.
For peptides, the most common bond to be broken is the peptide bond, generating b- and
y-type ions, and the bond between the alpha- and beta- carbons, which usually just generate atype ions. The b- and y-type ions are the starting point to constructing a hypothetical peptide
sequence.
Peptide fragmentation with Collision-Induced Dissociation. Collision-induced
dissociation creates ion fragments by breaking one bond in a peptide or protein, when sample
ions are allowed to collide with a neutral molecule, such as nitrogen or argon gas. The fragments
of most interest are the ones involving a break in the peptide backbone. The fragmentation
patterns provide sequence information of peptides and proteins [37]. The most common are a-,
b-, and y-ions. These ions have a charge of positive one. An a-ion is formed by breaking the
carbon-carbon bond between the α-carbon (carbon closest to the side-chain) and the carbonyl
carbon in the peptide, with a charge retained at or near the N-terminus, a b-ion is formed from an
amide (i.e. peptide) bond break, with a charge retained at or near the N-terminus, and a y-ion is
formed from a peptide bond break, with a charge retained at or near the C-terminus [38]. The aand b-ions contain amino acid sequence from the N-terminus up to the amino acid next to the
cleaved bond, and the y-ions contain amino acid sequence information from the amino acid next
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to the cleaved bond up to the C-terminus For tandem mass spectrometry of peptides or proteins,
immonium ions consisting of a single amino acid, minus CO2 and a proton, are generated. The
presence of a particular immonium ion or related ion can suggest the presence of a particular
residue in the peptide or protein [39, 40]. Not all amino acid residues have an associated
immonium ion, and the lack of an immonium ion does not necessarily mean the corresponding
amino acid is not present in an ion peak.
Triple-Quadrupole mass spectrometry for peptide analysis. A triple quadrupole mass
spectrometry has two quadrupole units, connected by one quadrupole between them where
collision-induced dissociation can take place. The first quadrupole (Q1) can act as a mass filter,
selecting for an ion with a specific m/z value. The second quadrupole (q2) is the collision cell.
The third quadrupole (Q3) can measure what fragments are generated in the collision cell.
For peptide samples and organic samples in general, electrospray ionization (ESI) is the
preferred method for ionization. This ionization method is gentler than other methods, and for a
given molecule, products with multiple charges are possible, varying by the number of protons
added to the molecule. The fact that multiple charges are possible with ESI is helpful in peptide
analysis, since it is likely that many of the ions generated will have an m/z value below the
maximum m/z range of the mass spectrometer. Otherwise, the molecule ion may not be visible
on the mass spectrum, if all of its ions exceed the maximum range of the instrument. To perform
ESI, the analyte is dissolved in water mixed with an organic solvent, such as methanol or
acetonitrile, and a high voltage is used to evaporate the organic solvent and impart a charge to
the analyte.
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Goals of the Project
The primary purpose of the project was to evaluate four methods of collecting pheromone
from Hymenochirus sp. males. The four methods evaluated were electrostimulation,
norepinephrine injection, GnRH injection, and breeding gland homogenization. The tools used
to analyze each method were HPLC and mass spectrometry.
The two specific goals of the project were, firstly, to compare the HPLC and MS data for
male and female samples collected by a particular method, looking for compounds that were
present in the male sample but not the female sample, and secondly, to find which collection
methods gave HPLC and MS data most similar to the gland sample. Compounds that were
found in a male sample collected by a particular method but not in the female sample could be a
pheromone. Likewise, compounds found both in the gland homogenate sample and a sample
collected by inducing gland secretion could be a pheromone.
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Chapter 2: Materials and Methods
Animals and Materials
Adult Hymenochirus sp. frogs were procured from two sources. The group of frogs
procured in 2013 was from Blue Lobster Farms (Madera, CA), and was used for the
electrostimulation samples and the first norepinephrine samples analyzed on the Waters
600/2489 HPLC. These frogs were from the same source as the frogs used in previous work by
Pearl et al. [22] in the Thomas lab, and were greyish in color. The second group was procured
from Tropical Haven (Modesto, CA) in 2013 and 2014, and was used for behavioral testing and
the rest of the sample collections. These frogs had a reddish-brown tint to their skin.
Frogs were housed at 28 °C in sex-segregated 10-gallon glass aquaria, with a light period
from 8 AM to 9 PM. However, the frogs were not sex-segregated from July 2014 to the end of
July 2015. They were fed ad-libitum with Tubifex worms, supplemented with Newt and
Salamander Bites from HBH Pet Products (Springville, UT), and New Life Spectrum Thera+A
from New Life International (Homestead, FL). The tanks were filled with deionized water, with
15 g of Doc Wellfish’s Aquarium Salt for Freshwater Fish (Aquarium Pharmaceuticals, Inc.,
Chalfont, PA) per 10 gallons. The water filter used was the Aqueon Quietflow 30 hang-on-back
filter. No aerator was used in the aquaria. Aquaria water was changed every three days. The
water in the aquaria was checked for pH, ammonia, nitrate, and nitrite about than once a month,
using an API freshwater master test kit. Frogs were healthy and behaved normally. The
mortality rate of the frogs was about one in fifty every month.
Approval for the use of frogs was obtained from the University of the Pacific IACUC
committee on August 13th, 2012, under the protocol 12R08a, and renewed annually until animal
work was completed.
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Solution Preparation
Solutions used for injection into frogs and the protease inhibitor cocktail were prepared
as described in Appendix A.
Sample Collection
Three methods of stimulating gland secretion were tested: electrical stimulation,
norepinephrine injection, and gonadotrophin-releasing hormone (GnRH). Gland excision was
also evaluated as a way of obtaining pheromone.
Electric stimulation. Ten frogs, either male or female, were stimulated with a SD9B
electrostimulator from Grass Instruments (Quincy, MA), using stainless steel multimeter probes
as electrodes. A glass bowl (diameter 15 cm x height 8 cm) was put on ice, and an aliquot
containing 0.6 mg of protease inhibitor cocktail was added to the glass bowl. Each frog was
stimulated with 0.75 V direct current of positive polarity, at 50 Hz with 4 ms length pulses, for
10 s on the post-axial skin over the breeding gland area. This procedure was based on the
procedures used by Tyler and associates [25]. Differences from the procedures used by Tyler
were that multimeter probes were used instead of platinum electrodes and the voltage used, 0.75
V, was incorrectly calculated and was too low. The Tyler study used a voltage ranging from 3 V
for frogs with a length of 20 mm, to 20 V for frogs with a length of 100 mm. For the
Hymenochirus sp. frogs used had a body length of 25 mm, and the voltage used should have
been 4.1 volts. The voltage used was 18% of what should have been used. The mistake was
discovered a long time after experiments had concluded. The stimulation was performed on the
same area of skin for both males and females. The current of the stimulation was not measured.
The area was then washed with 10 mL of water from a plastic syringe, after the frog was
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positioned over the glass bowl. The collected sample pooled together from 10 frogs was then
centrifuged at 13,000 rpm in conical tubes and then lyophilized and stored at -80 °C.
Norepinephrine injection. Ten males were injected in the dorsal lymph sac with 25 µL
of norepinephrine solution (2.36 mg/mL in amphibian Ringer’s solution), using a ½ inch 30
gauge needle, with the needle inserted parallel to the skin, either to the left or right side of the
spinal column (Figure 2-1), following the technique of Pearl et al. [22]. The frogs were then put
into a glass container in 75 mL of Mill-Q deionized water, and left for 15 min. The frogs were
removed and 25 mL of acetonitrile added, along with 2 mL protease inhibitor solution. The
sample was pipetted into glass scintillation flasks, lyophilized, and stored at -80 °C. This process
was also performed on ten female frogs.

A

B

Figure 2-1: Illustration of Injection into Dorsal Lymph Sac. A: Side view. B: Dorsal view, with
needle to the left of the spinal column.
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GnRH injection. Ten male frogs were injected in the dorsal lymph sac with 25 µL of
GnRH solution (12.5 µg/mL in amphibian Ringer’s solution), using a ½ inch 30 gauge needle,
following the technique of Pearl et al. [22]. After 3½ hours, the frogs were placed in a glass
container filled with 77 mL of Mill-Q deionized water, and left to sit for 15 min. The frogs were
then removed and 24 mL of acetonitrile added, along with 2 mL of protease inhibitor solution.
The sample was then pipetted into glass scintillation vials, lyophilized, and stored at -80 °C.
Gland collection accompanied with solid-phase extraction. Solid-phase extraction
was initially used on gland homogenate to elute only the hydrophilic portion. The pheromone is
likely hydrophilic, since it can be carried through water, as shown by the behavioral trials of
Pearl [22].
Ten male frogs were anesthetized by cooling a container housing the frogs in an ice bath
for 20 min. The frogs were beheaded with a razor blade and brain pithed with a sharp probe.
The skin over the glands was cut and the glands were removed and put into a microcentrifuge
tube on ice. The glands were ground for about 20 s with a plastic pestle, with the pestle being
rotated by hand in the microcentrifuge tube. One mL of 25% acetonitrile was added, and the
tube was centrifuged at 13,000 rpm for 3 min.
Two C-18 Sep-Pak filters connected in series were wetted with 2 mL of pure acetonitrile
using a plastic syringe,, and then equilibrated with 1 mL of 5% acetonitrile. The supernatant was
added to the Sep-Paks, and the Sep-Paks were washed with 0.5 mL of 5% acetonitrile. Then the
sample was eluted three times, with 1 mL aliquots of 30% acetonitrile, then 40%, then 50%, and
the elutant collected. The elutant was then lyophilized. Another elution was made with 1 mL of
60% acetonitrile, but this was not used.
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Gland collection without Sep-Pak separation. Ten male frogs were anesthetized,
euthanized, and glands removed from them as in the solid-phase extraction (SPE) gland
collection. One mL of a 30% acetonitrile solution, with 0.001% formic acid, was added to the
tube, the gland ground with a plastic pestle for 20 s, sonicated on ice in 10 one-second pulses,
and the tube centrifuged at 13K rpm for 5 min, and supernatant collected. Afterwards, 1 mg of
protease inhibitor was added. The supernatant was lyophilized and then stored at -80 °C.
Dates of collection. Electrostimulation samples were collected from male frogs on
10/17/2013, using stimulation of voltage 0.75 V. The female electrostimulation sample was
collected on 3/31/2013. Glands were harvested on two separate occasions, both times ten male
frogs were euthanized and glands removed. The dates were 3/5/2014, where Sep-Pak separation
was done, and 6/12/2014, when Sep-Pak separation was not performed on the gland sample, but
sonication of the sample was performed. The norepinephrine-induced sample from males was
taken on 3/30/2014. The norepinephrine-induced sample from females was taken on 3/24/14.
GnRH-induced samples from males were taken on 4/4/2014, 2/3/2015, and 3/18/2015. Only the
first collection of male GnRH samples used gender-segregated males; the rest used males cohabitating with females. The collection on 2/3/2015 used 30 µL of GnRH instead of 25 µL.
Twenty-five microliters is already a very strong dose, and using 30 µL in a trial would not make
much of a difference. The GnRH sample from females was collected on 1/27/2015.
The amount of time between samples being taken was to be at least two weeks apart, to
allow the frogs to regenerate the peptides and other contents of the secretions.
Purchased peptide. Hymenochirin 14B was purchased from New England Peptide
(Gardner, MA). Quality testing performed by the company indicated >=95% of HPLC area was
the peptide, and documentation said traces of trifluoroacetate salts would be in the sample. The
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peptide was received as a lyophilized sample at room temperature, and was stored at -80 °C. For
HPLC and MS analysis, lyophylized samples of the peptide were re-constituted with 1 mL of 1:1
acetonitrile/water, to a concentration of 1 mg/mL, as needed.
Analytical Chemistry Techniques
Analytical techniques used include HPLC and MS. HPLC was used to map out the
hydrophobicity of the compounds in each sample with an eye to isolating a particular range of
compounds with similar hydrophobicity. MS was used to get an overview of the components in
each sample, and to obtain peptide sequence of components that were peptides.
HPLC. HPLC was performed on six different types of sample. The first two types,
electrostimulated male and female, were conducted on a Waters 600/2489 HPLC. The other four
types, norepinephrine-stimulated males, norepinephrine-stimulated females, GnRH-stimulated
males, and breeding gland homogenate, were analyzed with an Agilent 1100 HPLC.
Waters 600/2489 HPLC. The Waters (Milford, MA, USA) 600/2489 HPLC consists of
the Waters 600 gradient pump, an analytical injection port, and a Waters 2489 dual-wavelength
UV detector. The column used was a Waters Symmetry C-18 analytical reverse-phase column,
4.6 mm internal diameter and 15 cm length, with 5 µm pore size. The Waters HPLC was used to
analyze the first norepinephrine-treated frog samples and electrostimulated frog samples.
Agilent 1100 HPLC. The Agilent (Santa Clara, CA, USA) 1100 HPLC system consists
of an Agilent HPLC gradient pump, a G1329A auto-sampler, a G1327A auto-injector, and a
G1315 dual-wavelength UV detector. The column used was the same Waters Symmetry column.
Wavelengths measured. All HPLC experiments measured absorbance of ultraviolet light
at two wavelengths: the first wavelength was either 200 nm or 214 nm, which are both within the
wavelength range maximally absorbed by the peptide bond, and the second was 280 nm, which
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is the wavelength maximally absorbed by double bonds. A chromatograph peak on the 200 nm
or 214 nm plot would indicate the presence of peptide bonds, which are present predominately in
amino acids or proteins, and a peak on the 280 nm plot would indicate a compound containing
double bonds.
Mass spectrometry. There were two mass spectrometers available for this project in the
Chemistry department, both of them triple-quadrupole instruments. The Varian 320 was used for
four samples, and then needed repairs. The ThermoFinnegan TSQ Quantum mass spectrometer
was used for the rest of the samples.
Varian 320-MS Triple-Quadrupole ESI-MS. The Varian 320-MS has a mass range up to
m/z 2000 units. The triple-quadrupole enables it to perform collision-induced dissociation (CID)
during tandem mass spectrometry experiments. It supports both port injection, and a constant
flow from a syringe pump that enables steadier sample delivery and can allow even lowconcentration peaks to be sampled for fragmentation. Port injection uses the LC pump to deliver
sample at 20 µL/min, and syringe injection is 10 µL/min. The instrument was used at a
resolution of 0.7 m/z units, meaning that peaks must be separated by at least 0.7 m/z units to be
distinguished from each other. The resolution was defined by the Full Width of the peak at its
Maximum Height (FWHM).
ThermoFinnegan TSQ Quantum mass spectrometer. This triple-quadrupole mass
spectrometer has an operating range up to 1500 m/z units. It can perform collision-induced
dissociation (CID). Ionization is also done with ESI. This instrument was used once to analyze
four samples before it broke down: norepinephrine-induced males, norepinephrine-induced
females, homogenized gland sample, and GnRH-induced males. The instrument was used at a
resolution of 0.4 m/z units, meaning that peaks must be separated by at least 0.4 m/z units to be
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distinguished from each other. The resolution was defined by FWHM. These samples were
analyzed August 19-22, 2014.
Sample preparation. Each sample to be evaluated using mass spectrometry had been
previously lyophilized. Each sample was reconstituted on ice with 40:60 acetonitrile/water to
create 1 mL of 1 mg/mL solution. The solution was centrifuged at 6000 rpm for five min and
filtered with a Chromafil Xtra CA-20/25 0.20 µm syringe filter (Macherey-Nagel; Düren,
Germany). This initial solution was diluted 1:10 (100 µL added to 900 µL of 40:60
acetonitrile/water) and also by a further 1:10. The 1:100 (0.01 mg/mL) dilution was used for a
wide mass spectrum scan and for fragmentation experiments; the 1:10 dilution (0.1 mg/mL) was
used only when the mass spectrum was weak.
HPLC Gradient Settings
For all HPLC runs, for the first run of the day, the column was first equilibrated with
concentrations of HPLC-grade water and acetonitrile that are the same as the concentrations used
for the beginning of the run. Runs used HPLC-grade water with 0.002% v/v formic acid, and
acetonitrile with 0.001% v/v formic acid. Runs using the Waters 600/2489 equilibrated for about
5 min; runs using the Agilent 1100 equilibrated until the baseline was constant.
A gradient method was used for the run, with the percent of HPLC-grade water or
acetonitrile changing linearly between the specified timepoints (Table 2-1). The flow rate was
0.6 mL/min. From zero to 5 min, the column is equilibrated. Low organic solvent concentration
allows the sample to interact with the nonpolar column without much interaction with the liquid
mobile phase. The gradient portion runs for 60 min, and polar molecules elute before more
nonpolar molecules. The portion of the method from 65 to 80 min ramps down the percentage of
organic solvent so a new sample can be injected.
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Table 2-1: Gradient Method Used For HPLC Runs.
Time (min) Percent water Percent acetonitrile
0

85

15

5

85

15

65

15

85

80

85

15

Detection wavelengths used were 200 nm, which was previously used in our lab by Wang
et al. (2002) and close to the peak peptide bond absorption at 212 nm, and 280 nm, which is
around the peak absorption wavelength of aromatic amino acids. For the samples run with the
Waters HPLC instrument, the wavelength 214 nm was used instead of 200 nm, but both
frequencies are both in the range of maximum absorption of the peptide bond.
Peaks eluted between 5 and 65 min were of interest, since that is the gradient portion of
the run, and we can learn the concentration of acetonitrile required for a peak to elute.
Interpretation of MS Data
Interpreting tandem mass spectra of amino acids. Each tandem mass-spectrum was
analyzed for immonium ions corresponding to single amino acids being broken off the precursor
ion, which would indicate an amino acid. If a spectrum resembles one of an amino acid, the
distance between peaks was calculated and compared to the size of all 20 proteinogenic amino
acids. Good matches can be linked up to create putative longer fragments. This process was
automated using a Microsoft Excel spreadsheet. A Python program (Appendix B) was also
developed that automatically creates possible sequences from manually-entered mass spectra.
The idea of the Python program was to take each m/z values in a tandem mass spectrum,
and calculate the m/z value difference between it and a nearby m/z value. If the difference in
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m/z was the same number as the mass of an amino acid minus the mass of water, the two m/z
values likely represented the loss of that amino acid minus water. The Python program recorded
all pairs of m/z values matching the criteria of differing by the mass of an amino acid minus
water. The program then created chains of these pairs of m/z values, to create a hypothetical
amino acid sequence.
Database search. Peaks were submitted as search queries on the MassBank Project Java
applet [41] and compared to tandem mass-spectrum results of known molecules. The applet
returned a p-value for each database match.
Protein Prospector. The Protein Prospector website by UCSF had an online tool that
predicted a mass spectrum for an amino acid sequence [42]. Known sequences or guesses of an
amino acid sequence can be inputted and the predicted mass spectrum compared to obtained
mass spectrometry results.
AGADIR. The Center for Genomic Regulation provides an online tool to calculate the
helicity of a protein based on its amino acid sequence [43]. The tool was used to predict the
helicity of hymenochirin peptides.
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Chapter 3: Results
Masses of All Collected Samples Collected By Lyophylization
Lyophilized weights for electrostimulation samples were 17.4 mg for females, and 30.4
mg for males. Samples collected for HPLC analysis were weighed May 2, 2014. The male
norepinephrine sample lyophilized weight was 5 mg, the female norepinephrine sample was 5
mg, the male GnRH sample was 5 mg, and the male gland homogenate sample processed by
Sep-Pak purification was 3 mg.
For the samples used in MS experiments, the lyophylized weights were 1.2 mg for the
male norepinephrine sample, female norepinephrine sample, and the gland homogenate not
purified with Sep-Pak syringe filters. The male GnRH and female GnRH samples both were 5
mg.
Percentages of HPLC Peaks Absorbing at 200 or 280 Nm
For each of the four samples put through HPLC analysis using the Agilent 1100 HPLC
instrument (male and female norepinephrine samples, male GnRH sample, and breeding gland
sample), the number of peaks that absorbed at the wavelength 200 nm and/or at 280 nm was
tabulated (Table 3-1). Comparing the different samples, each sample had a similar proportion of
their peaks in the different categories, except for the male GnRH sample, where no peaks
absorbed at only 280 nm. Compounds that absorb only at 280 nm and not at 200 nm would have
conjugated double bonds, possibly aromatic, but have no peptide bonds, which would have their
max absorption at 200 nm. The male GnRH seemed to lack this type of compound.
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Table 3-1: HPLC Samples and Number of Peaks Absorbing at 200 Nm and/or 280 Nm. All
samples run using the Agilent 1100 HPLC instrument were included.
Total
number
of peaks

200 nm 280 nm 200 nm
280 nm only
peaks peaks only peaks peaks

Both 200
and 280 nm
peaks

Male
norepinephrine

71

58

32

39

13

19

Female
norepinephrine

61

53

23

38

8

15

Male GnRH

45

45

8

37

0

8

Breeding gland 37

33

18

19

4

14

HPLC Results for Electrostimulation Samples
Three electrostimulation samples were collected from males and put through HPLC
analysis. The first two male electrostimulation samples collected had noticeable peaks between
5 and 65 min (Figures 3-1 and 3-2), the gradient portion of the run. The HPLC chromatographs
for the first two collections contained many peaks that were in one of the chromatographs and
not the other. Both male electrostimulation runs shared some peaks that absorbed at 214 nm: the
peaks at 6.7, 12.3, and at 14.5 min. The third male electrostimulation sample had no peaks
between 5 min and 41 min (Figure 3-3).
The female electrostimulation sample (Figure 3-4) didn’t show many sharp peaks,
especially compared to the male samples. The female sample was only run through HPLC once.
The baseline absorption fluctuated by a large amount throughout the run. There were large peaks
at 6.5 and 7.2 min, absorbing at both 214 and 280 nm. There were very small peaks at 10.0,
12.0, 13.0, 13.9, and 16.6 min, absorbing at 214 and 280 nm. There were also four peaks
between 44 and 65 min (portion expected to have compounds of highest hydrophobicity), at
44.4, 49.1, 54.6,
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Figure 3-1: Male Electrostimulation Sample HPLC Chromatograph, February 7, 2013. A: 200
nm. B: 280 nm.
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Figure 3-2: Male Electrostimulation Sample HPLC Chromatograph, February 8, 2013. A: 200
nm. B: 280 nm.
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Figure 3-3: Male Electrostimulation Sample HPLC Chromatograph, October 30, 2013. A: 200
nm. B: 280 nm.
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Figure 3-4: Female Electrostimulation Sample HPLC Chromatograph. Sample was run February
6, 2013. A: 200 nm. B: 280 nm.
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and 65.6 min, absorbing at both 214 and 280 nm. None of these peaks were seen in the male
electrostimulation sample HPLC chromatograph.
HPLC Results for Norepinephrine-Injected Males and Females
Looking at the general shape of the HPLC chromatographs for male and female
norepinephrine samples (Figure 3-5 and 3-6), there was one big difference in the chromatograph
measured at 200 nm. There was a big peak at 6.4 min in the male sample that was not present in
the female sample. The peak only absorbed at 200 nm and not at 280 nm.
HPLC Results for GnRH-Injected Males
The HPLC chromatograph for the GnRH male sample (Figure 3-7) measured at 200 nm
had fewer peaks than the male and female norepinephrine samples (Figures 3-5 and 3-6). The
GnRH male sample did not have the peak at 6.4 min that was a male-only peak in the
norepinephrine sample. The GnRH male sample did have a prominent peak absorbing at both
200 nm and 280 nm, at 18.1 min, whereas the norepinephrine samples didn't have any prominent
peaks in the 280 nm chromatograph.
HPLC Results for Breeding Gland Extract
Homogenized breeding gland (processed with solid-phase extraction) had peaks that are
mostly unique (Figure 3-8) and not found in the other samples, except for a peak at 22.6 min
(absorbing at 200 nm) whose retention time corresponded to a 22.6 min peak (absorbing at 200
nm) in the GnRH sample (Figure 3-7). The breeding gland sample did not have the HPLC peak
at 6.4 minutes that was found only in the male norepinephrine sample (Figure 3-5).
Mass Spectrometry Samples
Mass spectrometry was performed on five types of samples. The five sample types were
norepinephrine-treated males, norepinephrine-treated females, gonadotropin-treated males,
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Figure 3-5: Male Norepinephrine Sample HPLC Chromatograph. Sample was run May 2, 2014.
A: 200 nm. B: 280 nm.
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Figure 3-6: Female Norepinephrine Sample HPLC Chromatograph. Sample was run May
4, 2015. A: 200 nm. B: 280 nm.
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Figure 3-7: Male GnRH Sample HPLC Chromatograph. A: 200 nm. B: 280 nm.
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Figure 3-8: Breeding Gland Sample HPLC Chromatograph. A: 200 nm. B: 280 nm.
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gonadotropin-treated females, and breeding gland homogenate. The concentration of sample
used for MS analysis was 0.01 mg lyophilized mass/mL.
MS Results for Breeding Gland Purified with C-18 Sep-Pak Filters
Mass spectrometry for the breeding gland processed with solid-phase extraction (SPE)
was performed using the Varian 320 mass spectrometer. The mass spectrum had large peaks at
m/z values 203.9, 484.8, and 558.9 (Figure 3-9). There was also a large peak at m/z value 391.3,
but it was present in the blank mass spectrum as well. The three peaks were put through CID
mass spectrometry.
Peak with m/z 203.9. This peak was put through tandem mass spectrometry using the
mass spectrum gland sample processed with SPE (Figure 3-10), and the mass spectrum of the
sonicated gland not processed with SPE (Figure 3-11). In the breeding gland sample processed
with SPE, the ion fragmented easily with the voltage set to -20 V. The peak with m/z value 91.7
could be the common fragment C6H5-CH2 (m/z of 91). These two peaks at m/z values 78.0 and
91.7 suggested a benzene ring may be present. There was no molecular peak present in the
spectrum; the highest intensity peak was at m/z value 103.9. There was a loss of m/z 17
(possibly OH) between the peak with m/z 203.9 to the peak with m/z 187.1. The gland sample
not processed with SPE also had the peak of m/z 203.8, and the tandem mass spectrum was
largely the same, but the spectrum was more detailed, showing additional peaks of low intensity
(Figure 3-11).
Peak with m/z 484.8. This peak was put through tandem mass spectrometry using the
mass spectrum gland sample processed with SPE (Figure 3-12), and the mass spectrum of the
sonicated gland not processed with SPE (Figure 3-13). In the gland sample processed with SPE,
the ion fragmented easily, at -20 V. There were two instances of loss of water (m/z difference of
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Figure 3-9: Breeding Gland Homogenate Processed by Solid-Phase Extraction Mass Spectrum.
The Varian 320 mass spectrometer was used.
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Figure 3-10: Breeding Gland Homogenate Processed by Solid-Phase Extraction, Mass Peak with
M/z Value of 203.9, Tandem Mass Spectrum. The Varian 320 mass spectrometer was used.
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Figure 3-11: Sonicated Breeding Gland Homogenate, Not Processed by Solid-Phase Extraction,
Mass Peak with M/z Value of 203.8, Tandem Mass Spectrum. ThermoFinnegan TSQ Quantum
mass spectrometer was used.
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Figure 3-12: Breeding Gland Homogenate Processed by Solid-Phase Extraction, Mass Peak with
M/z Value of 484.8, Tandem Mass Spectrum. The Varian 320 mass spectrometer was used.
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Figure 3-13: Sonicated Breeding Gland Homogenate, Not Processed by Solid-Phase Extraction,
Mass Peak with M/z Value of 485.2, Tandem Mass Spectrum. The ThermoFinnegan TSQ
Quantum mass spectrometer was used.
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18), between peaks of m/z values 484.8 and 443.1, and between peaks of m/z values 243.9 and
225.5. There seemed to be a loss of a fragment of m/z value 42, from m/z value 484.8 to m/z
value 443.1, which could be propene (C3H6, difference of 42 m/z units). In the gland not
processed with SPE, the mass spectrum showed an additional loss of water between m/z values
184.0 and 201.8 (Figure 3-13).The mass spectra from both breeding gland samples suggest the
molecule was not a peptide, which would likely have more evenly spaced peaks, with fairly
similar intensity values.
Peak with m/z 558.9. This peak was put through tandem mass spectrometry using the
mass spectrum gland sample processed with SPE (Figure 3-14), and the mass spectrum of the
sonicated gland not processed with SPE (Figure 3-15). In the gland sample processed with SPE,
the ion fragmented readily at -20 V. On the lower end of the mass spectrum, there looked like
there were two fragment losses of m/z value 48, from m/z value 323.1 to m/z value 275.3, and
from m/z value 275.3 to m/z value 227.0. The significance of the two losses of m/z value 48 was
unknown. On the upper end of the mass spectrum, there seemed to be a loss of a fragment of
m/z value 34, from m/z value 558.9 to m/z value 523.3, which could be a loss of H2S. The gland
sample not processed with SPE had a much more detailed mass spectrum.
MS Results for Breeding Gland without C-18 Sep-Pak Filter Purification
The second gland homogenate sample was not put through solid-phase extraction with a
Sep-Pak, and had been processed with an ultrasonic sonicator for 15 s. This second sample was
analyzed with the ThermoFinnegan TSQ Quantum mass spectrometer, as opposed to the Varian
320, which was used for the gland sample processed with SPE. MS peaks found in this
sonicated gland sample (Figure 3-16) were very similar to those of the Sep-Pak processed gland
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Figure 3-14: Sonicated Breeding Gland Homogenate, Not Processed by Solid-Phase Extraction,
Mass Peak with M/z Value of 558.9, Tandem Mass Spectrum. The Varian 320 mass spectrometer
was used.
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Figure 3-15: Sonicated Breeding Gland Homogenate, Not Processed by Solid-Phase Extraction,
Mass Peak with M/z Value of 559.2, Tandem Mass Spectrum. The ThermoFinnegan TSQ
Quantum mass spectrometer was used.
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Figure 3-16: Sonicated Breeding Gland Homogenate, Not Processed by Solid-Phase Extraction
Mass Spectrum. Sample was collected on June 12, 2014. Mass spectrometry was conducted on
August 19, 2014, using the ThermoFinnegan TSQ Quantum instrument. A: M/z range 50-335. B:
M/z range 330-670.
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sample, having m/z values of 204.0, 485.3, and 559.2. The tandem mass spectrometry data for
these peaks were also similar to the Sep-Pak processed gland sample (Figures 3-11, 3-13, and 315). There was a fourth prominent peak with an m/z value of 245.1, which was much more
prominent in this gland sample than the SPE-processed gland sample. A tandem mass spectrum
was obtained for this peak at 245.1 (Figure 3-17), and was found to be largely identical to that
for the peak with m/z value 204.0, with no molecular ion peak visible at m/z value 245.2, but a
small peak at 203.7. This seemed to confirm that this peak of m/z value 245.2 was of the same
molecule as that in the peak of m/z value 203.7.
MS Results for Norepinephrine-Treated Males
The mass spectrum for the norepinephrine-treated male sample showed many prominent
peaks (Figure 3-18), and tandem mass spectra were collected for many of these peaks. A peak of
m/z value 160 was put through tandem mass spectrometry, and the resulting spectrum was a
MassBank database match for serotonin (molecular weight 176.215, match score of 0.87851).
Serotonin would typically be produced by frog poison glands. The biggest breeding gland mass
spectrum peaks, with m/z values of 203.9, 245.2, 484.8, and 558.9, were represented in the male
norepinephrine sample mass spectrum. Comparing the male and female norepinephrine samples,
there was one peak, with m/z value 292.9, that was in the male norepinephrine sample (Figure 318) but not the female norepinephrine sample (Figure 3-19).
All of the hymenochirins predicted from cDNA by Matthijs [13] had at least some of their
predicted m/z values (Table 3-2) represented in the male norepinephrine mass spectrum. The
hymenochirins with the most prominent peaks were 1B-5B, 7B, and 13-14B. Also found was a
truncated hymenochirin with the amino acid sequence identical to the C-terminus of
hymenochirin 3B, 13B, or 14B. Some of the peaks with m/z values matching hymenochirins
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Figure 3-17: Sonicated Breeding Gland Homogenate, Not Processed by Solid-Phase Extraction,
Mass Peak with M/z Value of 245.2, Tandem Mass Spectrum. Mass spectrometry was conducted
on August 14, 2014, using the ThermoFinnegan TSQ Quantum mass spectrometer.
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Figure 3-18: Male Norepinephrine Sample Mass Spectrum. It was run using the
ThermoFinnegan TSQ Quantum mass spectrometer. Major peaks with m/z value matching a
hymenochirin are labeled with the hymenochirin name and predicted m/z value. Peaks marked
“T” matched the m/z values of the truncated hymenochirin found in this sample. A: M/z range 0400. B: M/z range 400-800. C: M/z range 800-1200. D: M/z range 1200-1500.
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Table 3-2: Predicted Hymenochirin Sequences and Newly Observed Hymenochirin Fragment
Sequence, and Their Predicted M/z Values. Predicted hymenochirin sequences were found by
Matthijs et al. [13]. Highlighting indicates areas where sequence is identical to fragment
sequence. Expected m/z values up to 1,000 use monoisotopic atomic masses; values over 1,000
use average atomic masses.
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were put through fragmentation MS, and the reconstructed amino acid sequences matched those
of known hymenochirins. Hymenochirins confirmed using fragmentation MS included
hymenochirins 3B/13B/14B (all three share same m/z value) at m/z values of 705, 940, and
1410, and the truncated hymenochirin found with an m/z value of 757.
Truncated Hymenochirin
A prominent mass spectrum peak, with m/z value 757, was found in the male and female
norepinephrine samples (Figures 3-18 and 3-19, respectively), and with much lower intensities in
both male and female GnRH samples (Figures 3-21 and 3-23, respectively). This peak’s tandem
mass spectrum (Figure 3-20), in the low m/z value portion, contained peaks with m/z values
expected from a peptide or protein [39, 40]. The tandem mass spectrum had numerous peaks of
similar intensity, spaced fairly evenly, which suggested it was an amino acid. The tandem massspectrum was analyzed using Excel spreadsheet formulas and the Protein Prospector website
suggested the fragment started with the residues FT and ended with TQ. There were prominent
peaks at the m/z values of 146.88 and 248.2. When these two peaks were inputted into the Excel
worksheet, it showed the two peaks could be the y1 and y2 fragments from the n-terminus,
representing the amino acid sequences F and FT. There was a prominent peak at the m/z value
of 200.15, which could have been an a2 fragment representing threonine (T) and glutamine (Q).
Hypothetical sequences were entered into the Protein Prospector website. This process revealed
that the spectrum peak of the m/z value 1366.77 could have been a b15 fragment if threonine was
the next-to-last amino acid, so the c-terminus looked like it was the sequence TQ. Looking at the
list of known hymenochirins amino acid sequences, the TQ sequence was found in the Cterminus of four hymenochirins. The hypothetical sequence KVAKGVJSAVAGAJTQ (J standing
for residues that could be either isoleucine or leucine) was entered into Protein Prospector, and
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Figure 3-19: Female Norepinephrine Sample Mass Spectrum. The ThermoFinnegan TSQ
Quantum MS. Major peaks with m/z value matching a hymenochirin are labeled with the
hymenochirin number and letter, and its predicted m/z value. Peaks marked “T” matched the
m/z value of the truncated hymenochirin first found in the male norepinephrine sample. A: M/z
range 0-400. B: M/z range 400-800. C: M/z range 800-1200.

62
C

63
A

B

Figure 3-20: Male Norepinephrine Sample, Mass Peak with M/z Value of 757, Tandem Mass
Spectrum. Mass spectrometry was conducted on July 14, 2014, using the ThermoFinnegan TSQ
Quantum mass spectrometer. A: M/z range 0-385. B: 375-765. C: 758-1146. D: 1135-1500.
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the predicted m/z values (Table 3-3) matched up with the mass spectrum. The truncated
hymenochirin was 15 amino acids long, and had a mass of 1515 daltons. The peak of m/z value
757 in the male norepinephrine spectrum seemed to be the doubly-charged form of the molecular
ion, and the peak with m/z value of 505 was likely the triply-charged molecular ion.
MS Results for Norepinephrine-Treated Females
Two mass spectrum peaks were found in the norepinephrine-treated female sample
(Figure 3-19) that were not in other samples, with m/z values of 494.6 and 853.5. A peak of m/z
160 corresponding to the m/z value of serotonin was present. MS peaks were found
corresponding to all predicted m/z values for the known hymenochirins (Table 3-2). Some of the
most prominent peak m/z values corresponded to the predicted m/z values for hymenochirins
1B-5B, 7B, 7B, and 13-14B. The peak at the m/z value 716 was confirmed to be hymenochirin
5B using fragmentation mass spectrometry. The truncated hymenochirin present in the male
norepinephrine sample was also seen in this female norepinephrine sample.
MS results for GnRH-Treated Males and Females
Mass spectrometry runs were performed on four male GnRH sample collections. The
first MS trial of GnRH male samples was conducted using the Agilent 1100 mass spectrometer.
The three MS runs after the first run used the ThermoFinnegan TSQ Quantum mass
spectrometer, because the Agilent 1100 mass spectrometer was out of service at that time.
The first mass spectrometry run of GnRH male sample was conducted on August 21,
2014 (Figure 3-21), on the same week as the MS trials for the norepinephrine male sample,
norepinephrine female sample, and the gland not treated with Sep-Pak purification, all run using
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Table 3-3: Fragmentation Prediction for the Truncated Hymenochirin. Table was generated by
the Protein Prospector website [42].
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the ThermoFinnegan TSQ Quantum mass spectrometer. There were peaks in the GnRH male
sample that corresponded to all predicted m/z values for previously-known hymenochirins (Table
3-2). The most prominent peaks were those matching the m/z values of hymenochirins 1B, 3B,
4B, 8B, and 9B, and also the truncated hymenochirin, which had also been seen in the male and
female norepinephrine samples. The hymenochirin peaks were smaller in magnitude in relation
to the other peaks in the sample. Most of the hymenochirin peaks were less than 2% of the base
peak height. A peak of m/z 160, corresponding to the m/z value of serotonin that was found in
the male NE sample, was present in the male GnRH sample.
Looking at the four male GnRH mass spectra, only some of them had peaks matching the
largest breeding gland peaks of m/z values of 203.8, 245.2, 485.3, and 559.2. The sample run on
August 21, 2015 (Figure 3-21) had a small peak of m/z 203.3, but none of the other breeding
gland peaks. The sample run on March 17, 2015 (Figure 3-22) had a large peak at m/z value
203.0, a small peak at m/z value 244.6, and a peak at m/z value 485.0. The sample run on June
10, 2015 (Figure 3-23) had a large peak at m/z value 203.0 and a small peak at m/z value 244.9.
The sample run on June 17, 2015 (Figure 3-24) had a large peak at m/z value 204.0 and a small
peak at m/z value 244.3. In summary, the male GnRH mass spectra always contain a peak with
m/z value 203, and sometimes a peak at m/z value 245 or 485.
The male GnRH sample analyzed on March 17, 2015 (Figure 3-22) had two large peaks
at m/z values 532.0 and 701.9 that were not in the female GnRH sample (Figure 3-25). The peak
at 532.0 could only be reproduced once, in the sample analyzed on June 10, 2015 (Figure 3-23),
as a peak of m/z value 533.4. An MS peak of 702.0 was also present in the female
norepinephrine sample MS (Figure 3-19).
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Figure 3-21: Male GnRH Sample Mass Spectrum, August 21, 2014. The ThermoFinnegan TSQ
Quantum MS was used. Major peaks with m/z value matching a hymenochirin are labeled with
the hymenochirin number and letter, and its predicted m/z value. A: M/z range 0-400. B: M/z
range 400-800. C: M/z range 800-1200.
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Figure 3-22: Male GnRH Sample Mass Spectrum, March 17, 2015. The Varian 320-MS mass
spectrometer was used.
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Figure 3-23: Male GnRH Sample Spectrum, June 10, 2015. The Varian 320 mass spectrometer
was used.
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Figure 3-24: Male GnRH Sample Spectrum, June 17, 2015. The Varian 320 mass spectrometer
was used.
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Figure 3-25: Female GnRH Sample Mass Spectrum. The Varian 320 mass spectrometer was
used.
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The female GnRH sample (Figure 3-25) had the same mass spectrum peaks as the male
GnRH samples (Figures 3-21, 3-22, 3-23, 3-24 and 3-25). The female GnRH sample mass
spectrum had a peak matching one of the big breeding gland peaks, at m/z value 203.0.
Hymenochirins Found in Samples
In male and female norepinephrine-induced and GnRH-induced samples, peaks with m/z
values corresponding to all known hymenochirins were present. Peaks with m/z values
corresponding to hymenochirins 3B, 13B and 14B, in the male norepinephrine-induced sample,
were confirmed to be hymenochirins by tandem mass spectrometry analysis. The hymenochirin
5B was also confirmed by tandem mass spectrometry in the female norepinephrine-induced
sample.
HPLC Result for Synthetic Hymenochirin 14B
The synthetic hymenochirin 14B was put through HPLC, with absorption measured at
200, 212, and 280 nm (Figure 3-26). Hymenochirin 14B eluted at 27.1 min, an elution time not
seen in the other samples. The synthetic hymenochirin 14B HPLC peak absorbed at 200 nm, 212
nm, and 280 nm.
MS Results for Synthesized Hymenochirin 14B
The mass spectrum for synthesized hymenochirin (Figure 3-27) contained peaks with m/z
values predicted with Protein Prospector (Table 3-3), and also some m/z values that were not in
the prediction. The expected MS peaks were at m/z values of 470.6, 564.6, 705.4, 940.3, and
1410.75, which were all present. Unexpected peaks that we analyzed with tandem mass
spectrometry were at m/z values of 112, 141, 711, 806, 947, 1128, and 1215. For the unexpected
peaks of m/z values 711, 806, and 947, their tandem mass spectra contained peaks with m/z
values that were on the list of expected m/z values, suggesting they were the result of the peptide
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Figure 3-26: Synthesized Hymenochirin 14B Sample, HPLC Chromatograph. The Agilent 1100
mass spectrometer was used. A: 212 nm. B: 212 nm. C: 280 nm.
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Figure 3-27: Synthesized Hymenochirin 14B Sample, Mass Spectrum. The Varian 320 mass
spectrometer was used.
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interacting with another molecule of itself. The peak with m/z value 1128 fragmented into peaks
with m/z values of 940.5 and 1410.9, so the peak was likely the peptide paired with itself. The
fragment with m/z value 757 was not seen in the mass spectrum, which shows the truncated
hymenochirin was not a result of fragmentation of the hymenochirin 14B peptide.
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Chapter 4: Discussion
In this study, HPLC and MS revealed interesting data about Hymenochirus sp. secretions
elicited by norepinephrine or GnRH injection, and about breeding gland homogenate. HPLC
results showed that the male norepinephrine had a peak at 6.4 min not found in the female
norepinephrine sample. The male GnRH sample had no HPLC peaks that absorbed only at a
wavelength of 280 nm and not at 200 nm, unlike the norepinephrine and breeding gland samples.
Mass spectrometry results showed that there was a MS peak of m/z value 292.0 in the male
norepinephrine sample that was not in the female norepinephrine sample. There were four major
MS peaks for the breeding gland homogenate. All four peaks matched peaks in the male
norepinephrine mass spectrum, but male GnRH mass spectra generally only had peaks matching
the m/z values of 204 and 245, and not the other m/z values. Serotonin and a truncated
hymenochirin were found in norepinephrine-induced and GnRH-induced samples of both sexes.
HPLC Results for Electrostimulation
Two of the male electrostimulation sample HPLC runs did have three peaks in common
with each other, with retention times of 6.7 min, 12.3 min, and 14.5 min. Aside from these three
peaks, the male electrostimulation HPLC chromatographs had non-repeatable peaks. Neither
male sample chromatograph had peaks with retention times in common with the female
electrostimulation chromatograph. The HPLC results suggested that the electrostimulation
collection method was not effective, and the lack of peaks in the HPLC graphs showed that there
were very few substances coming off the frogs into the water. The HPLC peaks seen were
generally fairly small for both male and female samples. Electrostimulation, as done in this
study was not effective in eliciting skin secretions.
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Previous studies using electrostimulation were successful in causing skin to release
peptides [25, 28-32]. The studies have all used stimulation voltages above the voltage used in
this study, which was 0.75 V. Tyler and associates (1992) used a current from 3 V to 20 V,
depending on body length (which ranged from 20 mm to 100 mm) [25], Marenah and associates
(2004) used currents of 5 V [28], Wu and associates (2011) used 6 V [29], and You and
associates (2009) used 6 V [30]. The voltage used in this study was calculated incorrectly, and
should have been 4.1 V instead of 0.75 V, based on the voltages used by Tyler and associates
(1992) [25]. The voltage used was 18% of the voltage that should have been used. The studies
by Tyler and associates (1992) [25], Marenah and associates (2004) [28], Chen and associates
(2003) [31], and Chen and associates (2005) [32] used platinum electrodes, and the articles by
Wu and associates (2011) [29] and You and associates (2009) [30] did not mention the type of
electrodes used.
The amount of current delivered through electrical stimulation was the most important
parameter. The sinus gland of the Cardisoma carnifex and Portunus sanguinolentus crabs had
been shown to release hormone in increasing amounts for increasing current intensities [44]. The
secretion of the breeding gland would also be expected to be dependent on current intensity of
the electrical stimulation used. Ohm's law states that the current through a conductor is given by
I=

V
,
R

(1)

where I is current, V is the voltage across the conductor, and R is the resistance of the conductor.
If resistance were constant, current and voltage would be directly correlated. Using electrical
stimulation with a voltage 18% of the correct voltage would mean the current of the electrical
stimulation would also be 18% of the correct current, if the resistance were the same. Stainless
steel multimeter probes have a higher resistance than platinum electrodes. If the voltage used
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were the same, according to Ohm's law, the stainless steel micrometers would have less current
moving through them. The lower voltage used for stimulation and the use of stainless steel
electrodes instead of platinum electrodes both would cause the electrical current sent to the
breeding gland to be lower than the proper electrical current. The lower current used was very
likely to be insufficient to stimulate the breeding gland to secrete.
HPLC Chromatographs of Male and Female Norepinephrine Samples
The HPLC chromatograph for the male norepinephrine sample (Figure 3-5) had a peak at
6.4 min that was not in the female norepinephrine sample (Figure 3-6). The peak absorbed at
both 200 and 280 nm. The peak at 6.4 min was not found in other samples. This HPLC peak
could contain a male pheromone, since it was only found in the male sample. This result was
similar to the result found by [14], where they collected samples from electrically-stimulated
glands of Litoria splendida frogs and found the male HPLC chromatograph to contain a peak not
found in the female chromatograph.
The MS data for the male and female norepinephrine samples (Figures 3-18 and 3-19)
showed that there was a peak of m/z value 292.9 that was present for the male sample but not for
the female sample. This might have been related to the HPLC peak found only in the male
sample chromatograph.
Mass Spectrum Difference between Male and Female Norepinephrine Samples
Comparing the mass spectra of male and female norepinephrine samples (Figures 3-18
and 3-19, respectively), there was one mass spectrum peak present only in the male sample, with
an m/z value of 292. The mass spectrum peak could be of a pheromone compound, since it was
only in the male norepinephrine-induced sample and not the female norepinephrine-induced
sample. It was unknown if the ion peak was related to the HPLC peak found only in the male
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norepinephrine chromatograph with a retention time of 6.4 minutes (Figure 3-5). The HPLC
peak was not noticed at the time, so no mass spectrum data was obtained for the HPLC peak.
Lack of 280 Nm-Only Peaks in Male GnRH HPLC Chromatograph
Between four samples put through the Agilent 1100 (male and female norepinephrine,
male GnRH, and breeding gland samples), the male GnRH sample was the only one that
completely lacked HPLC peaks absorbing at the 280 nm wavelength and not absorbing at 200
nm (Table 3-1). Compounds that would absorb at 280 nm and not at 200 nm would compounds
with some kind of carbon-carbon or carbon-nitrogen double bond that absorb at 280 nm, but
lacking peptide bonds, which would have peak absorption at 200 nm. This result showed that
male and female norepinephrine samples and the breeding gland sample had some compounds
with double bonds involving carbon, and without peptide bonds. However, the male GnRH
sample did not have these compounds. No female GnRH sample was analyzed with HPLC, so it
was unknown if the female GnRH sample also lacked these compounds. A possible explanation
is that norepinephrine injection stimulates secretion more generally, and was able induce the
secretion of compounds with double bonds but no peptide bonds, but GnRH injection did not
cause the compounds to be secreted. The breeding gland homogenate did have such compounds
that absorb at 280 nm and not at 200 nm, presumably because it consisted of cell contents, which
would have many diverse compounds, including some that absorb at 280 nm and not at 200 nm.
Male and Female GnRH MS results
Male and female GnRH mass spectra generally had the same peaks, except in two
samples. The sample analyzed on March 17, 2015 (Figure 3-22) had two large peaks, at m/z
values 532.0 and 701.9, which were not in the female sample. The sample analyzed on June 10,
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2015, had a peak of m/z value 533.4. The importance of these MS peaks was unknown, as they
were not consistently present in all four of the male GnRH sample mass spectra.
Male GnRH HPLC and MS Compared to Previous Study
Secretions elicited by GnRH injection in Hymenochirus sp. were previously studied [23],
with GnRH injections administered twelve and three hours before sample collection. The
previous study found an HPLC peak at 26.8 min that was present only in the male GnRH sample.
The current study did not find the 26.8 min HPLC peak in the male GnRH sample HPLC
chromatograph (Figure 3-7) or in any other HPLC chromatograph (Figures 3-1 to 3-6, 3-8).
Breeding Gland MS Results
Four major mass spectrum peaks were found in the breeding gland samples (both SepPak processed and not Sep-Pak processed samples), with m/z values of 204, 245, 485, and 559.
These major mass spectra were all analyzed with tandem mass spectrometry, but the tandem
mass spectra did not match any mass spectra in the MassBase database. The mass spectra were
of low-weight molecules, since the tandem mass spectra showed only low m/z fragments were
generated.
The sample processed with solid-phase extraction using Sep-Pak filters was very similar
to the sample that was not processed. This suggested that most compounds present in the gland
were soluble in 30% to 50% acetonitrile solutions, since those were the eluting solvent
concentrations used to elute the sample from the Sep-Pak filters.
The breeding gland sample had large peaks at m/z values of 203.9, 245.2, 484.8, and
558.9 (Figures 3-9 and 3-16). None of the four peaks were in the female norepinephrine sample
(Figure 3-19). The female GnRH sample did have a peak with m/z value 203.9 (Figure 3-23).
These four major peaks were all shared between the breeding gland sample and the male
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norepinephrine sample (Figures 3-9, 3-16, and 3-18). In contrast, the male GnRH samples only
shared the peak at m/z value 203.9 and 245.1, and the sample run on March 17, 2015 did have a
peak with an m/z value of 485.1 (Figure 3-21, 3-22, 3-24, and 3-25). Norepinephrine injection
was better than GnRH injection in inducing secretion of the compounds that made up the four
major MS peaks of the breeding gland mass spectrum.
Serotonin in Norepinephrine and GnRH Samples
Serotonin was present in the male and female norepinephrine samples and the male and
female GnRH samples. Serotonin identity was confirmed by tandem mass spectrometry.
Serotonin was expected to be present, as a defensive molecule made by venom glands in frogs
[45]. The venom glands are innervated by the sympathetic nervous system [31], which is
activated by norepinephrine. GnRH samples also had an MS peak with the m/z value for
serotonin. GnRH is not known to stimulate venom glands, so it would not be expected to cause
the release of serotonin. The most likely explanation is that the stress caused by the handling of
the frogs for injections caused the frogs to release compounds from their venom glands as a
defense mechanism. This could be confirmed by injecting the frogs with placebo and checking if
the mass spectrum results contain a serotonin peak.
Previous Hymenochirin Research
Previous HPLC and mass spectrometry work by Mechkarska et al. [11] showed that
hymenochirins 1B-5B were present in norepinephrine-induced samples from Hymenochirus
boettgeri. The hymenochirins 6B-14B were subsequently predicted by Matthijs et al. [13], from
their cDNA library prepared from Hymenochirus boettgeri breeding gland and skin extracts. In
this current study on Hymenochirus sp., mass spectrum peaks of m/z values matching those
expected for hymenochirins 1B-14B were observed, in both norepinephrine-induced and GnRH-
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induced samples of both sexes. In this study, a truncated hymenochirin was observed in the mass
spectrum data for norepinephrine-induced samples of both sexes. This is the first time that a
truncated hymenochirin has been found. The truncated hymenochirin's primary sequence
matched that of the C-terminus of hymenochirins 3B, 13B, and 14B.
Hymenochirins Found
The mass spectroscopy results suggested that all known hymenochirins, (i.e.
hymenochirins 1B-14B) were present in all samples consisting of skin secretions: both
norepinephrine-stimulated and GnRH-stimulated samples, of both sexes. Most of the predicted
hymenochirin m/z values were seen in the mass spectra. Some mass spectrum peaks were
confirmed to be hymenochirins using tandem mass spectrometry.
Truncated Hymenochirin
The truncated hymenochirin was found in both norepinephrine- and GnRH-induced
samples, of both sexes. The truncated hymenochirin found was 16 amino acids long, as opposed
to the full length of 28 for hymenochirins 3B, 13B, or 14B. Sixteen amino acids is too few to
form a helical structure. Using the AGADIR online helicity calculator, the helicity of the
truncated hymenochirin was calculated to be 0.17, as opposed to 0.62 for the full-length peptide.
Also, its sequence contained only two cationic amino acids, whereas the full-length had five
cationic amino acids and two anionic amino acids. Therefore, the truncated hymenochirin would
not be effective as an antimicrobial peptide, in contrast to hymenochirins 1B through 5B, which
were previously found to have antimicrobial properties [11]. The truncated hymenochirin is
unlikely to be a male pheromone, since it is present in both males and females. It is unknown
whether it has acquired a new function, or is still just a version of the protein with a deleted N-
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terminal portion. Unpublished data in our lab by Minjin Ko, found a gene encoding for the
truncated hymenochirin in a cDNA library generated from the frogs.
Behavioral Study of Female Reaction to Collected Samples, for Future Research
For the purpose of investigating future avenues of research, behavioral trials were
performed to test whether female Hymenochirus sp. frogs were attracted to any collected
samples. The procedures used were the same as those used by Pearl and associates [22].
Samples tested had been put through the HPLC analysis process before being used for the
behavioral study. Samples tested were the male norepinephrine-stimulated sample with HPLC
elution time of 25.70-35 minutes, the gland sample with elution time 6.5-25.7 minutes, and the
gland sample with elution time of 25.7-33.8 minutes. The female frogs did not respond to any of
the samples. For the male norepinephrine sample, the HPLC eluting at 6.4 min not found in the
female norepinephrine sample was not tested, because it was not noticed until a long time after
behavioral testing had finished. Female frogs were also not attracted to water housing males that
had been injected with 25 µL of 12.5 µg/mL GnRH solution 3.5 hours prior to the behavioral
trial.
Possible reasons why the behavioral testing did not find any female response to stimuli
were the temperature of the water in which the frogs resided before and during the behavioral
tests, the possibility that the males were at that time incapable of secreting pheromone, the
possibility that females were not in breeding condition at the time, and the possibility that the
frogs were unhealthy. The frogs used in the behavioral tests were removed from their aquaria 3.5
hours prior to the tests, and put into jars containing deionized water. The water in the aquaria
was kept at 25 °C, but the water in the jars was at room temperature, which at the time was about
23 °C. The water in the maze had the temperature measured at the beginning of each behavioral
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trial, and was 21.8 °C on average. The lower water temperature could have caused females to
not respond to a pheromone. The temperature issue could be avoided by using tank heaters to
keep the water temperature at 25 °C before and during behavioral testing. The possibility that
male frogs could not secrete pheromone was less likely, as the breeding glands were observed to
be 2 mm in diameter without GnRH injection. To make sure the male frogs were releasing
pheromone, the size of the breeding gland could be observed after injecting the frogs with
GnRH, to see if the glands increase in size in response to GnRH as described by Vahamaki and
Thomas (1997) [33]. It was possible that female frogs were not in breeding condition, so that
they would not be seeking males. This possibility could be tested by putting females with males
who are at the third or fourth level of sexual readiness, as described by Rabb and Rabb (1963)
[21]. The females' reaction to the males could indicate whether they are in breeding condition.
It was possible that the frogs were unhealthy, and therefore not in breeding condition. The frogs
seemed healthy, did not seem stressed or in distress, and were fairly active in their movement.
This possible reason could be tested by putting males and females together and seeing if they
engage in courtship and mating behavior, or by consulting a veterinarian or frog expert to
evaluate the health of the frogs.
The behavioral testing done showed a lack of female response to male frogs injected with
GnRH, and to some HPLC fractions of some of the samples collected. The lack of response
meant that behavioral testing could not confirm the analytical chemistry experimental results.
The analytical chemistry results did show differences in HPLC chromatographs and mass spectra
of male and female norepinephrine-induced samples, which indicated there could be a male
pheromone present in the male norepinephrine-induced sample. Without a positive behavioral
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test result, the HPLC chromatograph and mass spectrum differences could not be definitively
connected to the presence of a pheromone.
Further Research
Male secretions induced by norepinephrine injection should be studied further, as there
was a HPLC peak at 6.4 minutes (Figure 3-5) that was not found in the female sample (Figure 36). The HPLC peak should be collected and put through mass spectrometry to analyze what
compound is in the HPLC peak. The HPLC peak could possibly be tested in a behavioral trial to
test whether females were attracted to it. The fraction would need to be frozen immediately after
it eluted from the HPLC column, and it would need to be lyophilized to get rid of the acetonitrile
solvent.
Electrostimulation of breeding glands should be tried again, using a proper value for the
voltage similar to the voltages used in other studies. Platinum electrodes should be used to
ensure that the electrical current delivered to the breeding gland is comparable to the electrical
current delivered in other studies.
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APPENDIX A: SOLUTION PREPARATION
Materials Used
The following materials were purchased:
1. DL-norepinephrine hydrochloride (Sigma-Aldrich)
2. [des-Gly10,D-Ala6]-Lutenizing Hormone, gonatotropin releasing hormone ethylamide
(GnRH, Sigma-Aldrich)
3. Protease inhibitor cocktail, lyophylized powder (Sigma-Aldrich)
4. HPLC-grade acetonitrile (EMD)
5. Waters Sep-Pak C18 Classic Cartridge, with 360 mg sorbent, 55-105 µm particle size,
part no. WAT051910
6. 50% w/v formic acid solution (Sigma-Aldrich)

Preparation of Ringer’s Solution
Ringer’s solution was prepared using the following recipe:
6.60 g NaCl
0.150 g KCl
0.190 g CaCl2•2H2O
0.200 g NaHCO3
The solution was tested with a pH meter and adjusted to a pH of 7.8 if necessary with
NaHCO3.
Preparation of GnRH Solution
A 10x master mix of GnRH was prepared at 125 µg/mL in a glass vial. 250 µL aliquots
of 1x solution, at 12.5 µg/mL were stored in 500 µL Eppendorf tubes. The solution was made
November 11, 2013 and stored at -20 °C.
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Preparation of Norepinephrine Solution
A 2.5 mL norepinephrine solution was prepared using 5.9 mg of norepinephrine, making
the solution 2.36 mg/mL. 250 µL aliquots were stored in 500 µL Eppendorf tubes. The solution
was made March 24, 2014, and stored at -20 °C.
Preparation of Protease Inhibitor Solution
Six mg of protease inhibitor cocktail was dissolved into 20 mL of Mill-Q water, and the
solution was divided into 10 aliquots of 2 mL each.
Preparation of HPLC-Grade Water with 0.002% V/V Formic Acid
Ten µL of 50% v/v formic acid was added to 1 L of HPLC-grade water obtained from a
Milli-Q Academic water filter.
Preparation of HPLC-Grade Acetonitrile with 0.001% V/V Formic Acid
Twenty µL of 50% v/v formic acid was added to 1 L of HPLC-grade acetonitrile.
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APPENDIX B: PYTHON PROGRAM CODE USED TO ANALYZE MS/MS DATA FOR
AMINO ACIDS
A Python program was written and used to analyze mass spectra text files, to find pairs of
m/z values whose difference matched the weight of a proteinogenic amino acid. Pairs of amino
acids are generated for low m/z values, creating the first amino acid of a possible sequence.
Then the program attempts to grow a tree structure by extending the amino acid sequence. The
tree branches when there are multiple possibilities for the next amino acid. The program takes as
input a text file containing m/z values, separated by carriage returns. The output of the program
is a list of sets of two amino acids: with the end of one amino acid being at an m/z value that
starts the other amino acid. Lines starting with a pound sign are ignored. The program was
written in Python 3.6.
#!python3
import random
import math
workingDirectory="/home/vleung/Documents/Python_course/MSMS/"
global dictOfForwardTails
dictOfForwardTails={}
global dictOfTooShortAddresses
dictOfTooShortAddresses={}
global listOfDisplayedAddresses
listOfDisplayedAddresses=[]
global reverseDictOfAllNodes
reverseDictOfAllNodes={}
global listOfForwardResidueChains
listOfForwardResidueChains=[]
global listOfReverseResidueChains
listOfReverseResidueChains=[]
diagnosticMode=True
class peakNode(object):
def __init__(self,value,startmz,endmz,residueTuple,intensityTuple=()):
self.value=value
self.listOfChildren=[]
self.listOfParents=[]
self.listOfChildrenN=[]
self.listOfParentsN=[]
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self.listOfAddresses=[]
self.blacklistedChildrenN=[]
self.purplelistedChildrenN=[]
self.blacked=False
self.purpled=False
self.parentWithBlacklist=-1
self.parentWithPurplelist=-1
self.startmz=startmz
self.endmz=endmz
self.residueTuple=residueTuple
self.residue=residueTuple[0]
self.intensityTuple=intensityTuple
def getValue(self):
return self.value
def addChild(self,node,deviation,residue="-",residueTuple="", previousResiude="-",
previousTuple=""):
#residue argument just for printing
if node.value not in self.listOfChildrenN:
self.listOfChildren.append((node,deviation))
self.listOfChildrenN.append(node.value)
print("Child "+str(node)+" added to "+str(self.value)+". "+str(previousTuple)+",
"+str(residueTuple))
def addParent(self,parent):
if parent.value not in self.listOfParentsN:
self.listOfParents.append(parent)
self.listOfParentsN.append(parent.value)
def addAddress(self,address):
self.listOfAddresses.append(address)
def getChildren(self):
return self.listOfChildren
def getChildrenIndices(self):
return self.listOfChildrenN
def getIntensityTuple(self):
return self.intensityTuple
def getParents(self):
return self.listOfParents
def getParentsIndices(self):
return self.listOfParentsN
def getResidue(self):
return self.residue
def getStartmz(self):
return self.startmz
def setmz(self,startmz,endmz):
self.startmz=startmz
self.endmz=endmz
def setIntensityTuple(self,intensityTuple):
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self.intensityTuple=intensityTuple
def setResidue(self,residueTuple):
self.residue=residueTuple[0]
def getEndmz(self):
return self.endmz
def addBlack(self,index):
self.blacklistedChildrenN.append(index)
def markBlack(self):
self.blacked=True
def isBlack(self):
return self.blacked
def storeParentWithBlacklist(self,index):
self.parentWithBlacklist=index
def unblack(self):
self.blacked=False
dictOfAllNodes[self.parentWithBlacklist].blacklistedChildrenN.remove(self.parentWithBlacklist
)
def addPurple(self,index):
self.purplelistedChildrenN.append(index)
def markPurple(self):
self.purpled=True
def isPurple(self):
return self.purpled
def storeParentWithPurplelist(self,index):
self.parentWithPurplelist=index
def unmarkPurple(self):
self.purpled=False
dictOfAllNodes[self.parentWithPurplelist].purplelistedChildrenN.remove(self.parentWithBlackli
st)
def __str__(self):
return str(self.value)
def __repr__(self):
return "peakNode("+str(self.value)+")"
class address(object):
def __init__(self,addressInListForm=[]):
self.listForm=addressInListForm
def addNodeIndex(self,index,dictionaryOfIndices):
self.listForm.append(index)
class nodeDict(dict):
def __init__(self, dictName):
self.dictName=dictName
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self.baseDict={}
def getDictName(self):
return self.dictName
def getDict(self):
return self.dictName
def addToDict(self, theKey, theEntry):
self.baseDict[theKey]=theEntry
def getResidue(self, index):
return self.baseDict[index].getResidue()
def getLength(self):
return len(self.baseDict.keys())
def addChild(self, recordIndex, entry1, entry2, entry3="-", entry4="", entry5="", entry6=""):
self.baseDict[recordIndex].addChild(entry1, entry2, entry3, entry4, entry5, entry6)
def addParent(self, recordIndex, objectToAdd):
self.baseDict[recordIndex].addParent(objectToAdd)
def getRecord(self, recordIndex):
return self.baseDict[recordIndex]
global dictOfAllNodes
dictOfAllNodes=nodeDict("dictOfAllNodes")
def readConfig(filename):
peakfile=open(filename, "r")
all = [ line.rstrip() for line in peakfile.readlines() ]
lines = []
lines2 = []
for line in all:
if len(line)==0:
continue
if line[0]=="#":
continue
lineSplit=line.split(" ")
lines.append(float(lineSplit[0]))
if len(lineSplit)>1:
if lineSplit[1]!="*":
lines2.append(float(lineSplit[1]))
return (lines, lines2)
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residues=[71.04,103.01,115.03,129.04,147.07,57.02,137.06,113.08,128.10,131.04,114.04,97.05,
128.06,156.1,87.03,101.05,99.07,186.08,163.06]
residuesL=["A","C","D","E","F","G","H","I/L","K","M","N","P","Q","R","S","T","V","W","Y"]
sortedResidues=residues[:]
sortedResidues.sort()
mzOfLargestAminoAcid=sortedResidues[-1]
residuesLtoNDict={"A": 71.04, "C": 103.01, "D": 115.03, "E": 129.04, "F": 147.07, "G": 57.02,
"H": 137.06, "I/L": 113.08, "K": 128.10, "M": 131.04, "N": 114.04, "P": 97.05, "Q": 128.06, "R":
156.1, "S": 87.03, "T": 101.05, "V": 99.07, "W": 186.08, "Y": 163.06}
residuesNtoLDict={71.04: "A", 103.01: "C", 115.03: "D", 129.04: "E", 147.07: "F",57.02:
"G",137.06: "H",113.08: "I/L",128.10: "K",131.04: "M",114.04: "N",97.05: "P",128.06:
"Q",156.1: "R",87.03: "S",101.05: "T",99.07: "V",186.08: "W",163.06: "Y"}
def getMw(residue):
#myIndex=residuesL.index(residue)
#return residues[myIndex]
return residuesLtoNDict[residue]
def withinRange(difference,residue,tolerance=0.85):
#If within range, returns 0
#Right now, is set to +/- 0.8 range
if setNewTolerance=="y":
tolerance=0.4
if difference-residue<-tolerance:
return -1
elif difference-residue>tolerance:
return 1
return 0
#return abs(difference-residue)<0.3
def within28(peak1,peak2,tolerance=0.8):
if abs(peak1-peak2)>tolerance:
return False
return True
def genDiffs():
#Output looks like [((A, 71.04), 94.0, 177.2, (.85, .65)), ...]
#output stored in genDiffsList
#The fourth element of the list is the intensities
trialDiff=0.0
global genDiffsList
genDiffsList=[]
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global genDiffsDict
genDiffsDict={}
genDiffsDictCounter=0
for e in range(0,len(peakList)-2):
for f in range(len(peakList[e+1:])):
trialDiff=peakList[e+1+f]-peakList[e]
#If the difference is biggest than than maximum
if trialDiff>mzOfLargestAminoAcid:
break
for residuemw in residues:
if withinRange(trialDiff,residuemw)==0:
#if there is no list of intensities
if len(peakList2)==0:
genDiffsList.append(((residuesNtoLDict[residuemw],
residuemw),peakList[e],peakList[e+1+f], (-1.0,-1.0)))
genDiffsDict[genDiffsDictCounter]=((residuesNtoLDict[residuemw],residuemw),peakList[e],pe
akList[e+1+f], (-1.0,-1.0))
genDiffsDictCounter+=1
else:
genDiffsList.append(((residuesNtoLDict[residuemw],
residuemw),peakList[e],peakList[e+1+f],(peakList2[e],peakList2[e+1+f])))
genDiffsDict[genDiffsDictCounter]=((residuesNtoLDict[residuemw],
residuemw),peakList[e],peakList[e+1+f],(peakList2[e],peakList2[e+1+f]))
genDiffsDictCounter+=1
#return genDiffsList

def createTree(dictToPopulate=dictOfAllNodes):
treeMade=False
rootIndices=list(range(len(genDiffsList)))
listOfRootNodes=[]
global listOfParentsIndices
listOfParentsIndices=[]
for e in range(len(genDiffsList)):
#create all nodes as objects, each with an index (stored as key),
dictToPopulate.addToDict(e,peakNode(e,genDiffsList[e][1],genDiffsList[e][2],genDiffsList[e][0
],genDiffsList[e][3]))
if diagnosticMode==True:
print("("+str(e)+",peakNode("+str(e)+","+str(genDiffsList[e][1])+","+str(genDiffsList[e][2])+","
+str(genDiffsList[e][0])+","+str(genDiffsList[e][3])+")")
keepAlive=dictToPopulate.getLength()*500
#dictOfAllNodes[11]=peakNode(11)
for e in range(dictToPopulate.getLength()):
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for g in range(e+1,len(genDiffsList)):
#test if too far apart on the list (by index)
if g-e>80:
break
for h in range(len(residues)):
if keepAlive<=0:
break
#If the m/z end of one pair matches the m/z beginning of another pair
if withinRange(genDiffsList[e][2],genDiffsList[g][1])==0:
#calculates the variance of the two residue m/w's added together from expected
twoResiduesMw=getMw(dictToPopulate.getResidue(e))+getMw(dictToPopulate.getResidue(g))
observedResidueMw=genDiffsList[g][2]-genDiffsList[e][1]
myVariance=observedResidueMw-twoResiduesMw
#?
knownTwoTimesSigma=0.8
knownSigma=knownTwoTimesSigma/float(2)
knownSigmaSquared=knownSigma**2
mu=twoResiduesMw
phi=math.e**((myVariance)**2/(2.0*knownSigmaSquared))/(knownSigma*(float(2)*math.pi)*0.5)
phiNormalizationDivisor=1/((knownSigma*2*math.pi)**0.5)
phiNormalized=phi/phiNormalizationDivisor
#store a child (with a pointer to the child record, the probability from the standard
distribution, residue letter for parent->child, and tuple of letter and the associated m/z
dictToPopulate.addChild(e,
dictToPopulate.getRecord(g),phiNormalized,genDiffsList[g][0][0],
genDiffsList[g][0],genDiffsList[e][0][0],genDiffsList[e][0])
dictToPopulate.addParent(g, dictToPopulate.getRecord(e))
listOfParentsIndices.append(e)
treeMade=True
listOfChildlessNodes=[]
listOfParentlessNodes=[]
for e in range(dictOfAllNodes.getLength()):
if len(dictToPopulate.getRecord(e).listOfChildren)==0:
listOfChildlessNodes.append(e)
if len(dictToPopulate.getRecord(e).listOfParents)==0:
listOfParentlessNodes.append(e)
if treeMade:
print("Tree created")
else:
print("No tree created")
def createReverseTree():
#Has to be updated with encapsulated dictOfAllNodes Object
treeMade=False
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rootIndices=list(range(len(genDiffsList)-1,-1,-1))
listOfRootNodes=[]
for e in range(len(genDiffsList)):
reverseDictOfAllNodes[e]=peakNode(e,genDiffsList[e][1],genDiffsList[e][2],genDiffsList[e][0],
genDiffsList[e][3])
keepAlive=len(reverseDictOfAllNodes)*500
for e in range(len(dictOfAllNodes)-1,1,-1):
for g in range(e-1,0,-1):
if e-g>80:
break
#e is bigger than f, so next line is reversed ([1] and [2])
if withinRange(genDiffsList[e][1],genDiffsList[g][2])==0:
reverseDictOfAllNodes[e].addChild(reverseDictOfAllNodes[g],genDiffsList[g][0])
reverseDictOfAllNodes[g].addParent(dictOfAllNodes[e])
treeMade=True
keepAlive-=1
else:
keepAlive-=1
if treeMade:
print("Reverse tree created")
else:
print("No reverse tree created")
def genReport():
#NEEDS TO BE UPDATED BEFORE USING
input=genDiffsList
reportFile=open(workingDirectory+"output"+str(peakList[-1])+".csv","wb")
for e in range(len(input)):
print((str(input[e][0])+","+str(input[e][1])+","+str(input[e][2])))
reportFile.write(str(input[e][0])+","+str(input[e][1])+","+str(input[e][2])+"\n")
reportFile.close()
def predictSequences():
for e in range(len(genDiffsList)):
aaSequence=[]
numSequence=[]
for f in range(len(genDiffsList-1-e)):
start=genDiffsList[e]
next=genDiffsList[e+1+f]
sequenceHasEnded=False
while not sequenceHasEnded:
if withinRange(next[1]-start[2],residue)==0:
aaSequence.append(start[0])
numSequence.append(next[1]-start[2])
start=next
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next=genDiffs
def convertToResidue(workingAddress):
workingAddressRes=[]
for e in range(len(workingAddress)):
workingAddressRes.append(genDiffsList[workingAddress[e]][0])
workingAddressResString=""
for e in range(len(workingAddressRes)):
if workingAddressRes[e]=="I/L":
workingAddressResString+="J"
else:
workingAddressResString+=workingAddressRes[e]
def processFinishedAddress(workingAddress,workingAddressResString,keepAlive,dictTo
Crawl):
if len(workingAddress)>=len(genDiffsList)/30:
if workingAddress not in listOfDisplayedAddresses:
dictToCrawl[workingAddress[-1]].addAddress(workingAddress)
listOfDisplayedAddresses.append(workingAddress)
print(">= #nodes/30: "+str(workingAddress))
print(workingAddressResString)
print("Address at "+str(workingAddress[-1]))
else:
addressHash=workingAddress[0]/10
if addressHash not in dictOfTooShortAddresses:
dictOfTooShortAddresses[addressHash]=[]
dictOfTooShortAddresses[addressHash].append(workingAddress)
#print "workingAddress: "+str(workingAddress)
#print "genDiffsList length: "+str(len(genDiffsList))
return keepAlive-1
def checkIfInTooShortDict(workingAddress):
addressHash=workingAddress[0]/10
dictYank=dictOfTooShortAddresses[addressHash][:]
if workingAddress in dictYank:
return True
return False
def checkWhetherInTooShort(workingAddress):
addressHash=workingAddress[0]/10
if addressHash in dictOfTooShortAddresses:
copyHashLookupResult=dictOfTooShortAddresses[addressHash][:]
if workingAddress in copyHashLookupResult:
return True
return False
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def checkIfAlreadyDisplayed(workingAddress):
if workingAddress in listOfDisplayedAddresses:
return True
return False
def newCrawl(startingNodeIndex,dictToCrawl=dictOfAllNodes):
def makePathChoice():
keepAlive1=1000
methodOfPathSelection="random"
#Processive path selection, not implemented
if methodOfPathSelection=="processive":
noMoreAvailablePaths=False
wrongPathChoice=True
lenOfChildren=len(dictToCrawl[currentLocation].getChildren())
pathChoice=0
while wrongPathChoice and pathChoice<=lenOfChildren:
if pathChoice==lenOfChildren:
print("pathChoice="+str(pathChoice))
keepAlive1-=1
noMoreAvailablePaths=True
elif not dictToCrawl[currentLocation].getChildren()[pathChoice].isBlack():
wrongPathChoice=False
else:
keepAlive1-=1
pathChoice+=1
if noMoreAvailableChoices:
break
elif methodOfPathSelection=="random":
wrongPathChoice=True
while wrongPathChoice==True and keepAlive1>0:
keepAlive1-=1
pathChoice=random.choice(list(range(len(dictToCrawl[currentLocation].getChildren()))))
if not dictToCrawl[pathChoice].isBlack():
wrongPathChoice=False
return pathChoice
return "He"
#keepAlive=len(genDiffsList)*28
keepAlive=len(genDiffsList)*9
print("keepAlive(naught)="+str(keepAlive))
address=[startingNodeIndex]
#?
noMoreAvailableChoices=False
while keepAlive>0 and not noMoreAvailableChoices:
#start making a chain from startingNode
workingAddress=[]
currentLocation=startingNodeIndex
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previousLocation=currentLocation
arrivedAtTerminus=False
workingAddress.append(startingNodeIndex)
while not arrivedAtTerminus:
if len(dictToCrawl[currentLocation].getChildren())==0:
#end of the chain
#print "length of children is 0"
if not workingAddress in dictToCrawl[currentLocation].listOfAddresses:
workingAddressResString=convertToResidue(workingAddress)
processOutput=processFinishedAddress(workingAddress,workingAddressResString,keep
Alive,dictToCrawl)
keepAlive=processOutput
else:
keepAlive-=1
arrivedAtTerminus=True
else:
pathChosen=makePathChoice()
try:
nextNodeIndex=dictToCrawl[currentLocation].getChildren()[pathChosen][0].value
except IndexError:
print("IndexError")
print("pathChoice: "+str(pathChosen))
print("currentLocation: "+str(currentLocation))
keepAlive-=10
#ignore path generated
arrivedAtTerminus=True
break
workingAddress.append(nextNodeIndex)
knownTooShort=checkWhetherInTooShort(workingAddress)
if knownTooShort:
#discard
arrivedAtTerminus=True
keepAlive-=1
break
else:
currentLocation=nextNodeIndex
#previousLocation=
def calculateAddressScore(address,dictWithTheNodes=dictOfAllNodes):
listOfIntensityTuples=[]
listOfPhiNormalized=[]
for element in address:
listOfIntensityTuples.append(dictWithTheNodes[element].getIntensityTuple())
#find index of "element," get the index of the next element, and pull phi from getChildren()
temporaryKeyList=list(dictWithTheNodes.keys())
positionOfElement=temporaryKeyList.index(element)
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copyOfElementChildren=dictWithTheNodes[element].getChildren()[:]
pulledPhiNormalized=-1.0
phiTotal=0.0
for child in copyOfElementChildren:
if str(child[0])==address[positionOfElement+1]:
pulledPhiNormalized=child[1]
listOfPhiNormalized.append(pulledPhiNormalized)
phiTotal+=pulledPhiNormalized
break
intensityTotal=0.0
for e in range(len(listOfIntensityTuples)):
if e==len(listOfIntensityTuples):
intensityTotal+=float(dictWithTheNodes.getDict()[address[e]][0].getIntensityTuple()[1])
intensityTotal+=float(dictWithTheNodes[address[e]][0].getIntensityTuple()[0])
intensityAverage=intensityTotal/float(len(listOfIntensityTuples))
print("intensityAverage: "+str(intensityAverage))
phiAverage=phiTotal/float(len(listOfPhiNormalized))
print("phiAverage: "+str(phiAverage))

def doCrawlAuto():
for e in listOfParentsIndices:
print("newCrawl("+str(e)+")")
newCrawl(e)
def doReverseCrawl(startingNodeIndex):
address=[startingNodeIndex]
keepAlive=len(genDiffsList)*28
currentLocation=startingNodeIndex
noMoreAvailableChoices=False
while keepAlive>0 and not noMoreAvailableChoices:
keepAlive-=1
workingAddress=[]
currentLocation=startingNodeIndex
previousLocation=currentLocation
arrivedAtTerminus=False
while not arrivedAtTerminus:
if len(dictToCrawl[currentLocation].getParents())==0:
if not dictToCrawl[currentLocation].isPurple():
dictToCrawl[currentLocation].markPurple()
if dictToCrawl[currentLocation].value!=dictToCrawl[previousLocation].value:
dictToCrawl[previousLocation].addPurple(currentLocation)
dictToCrawl[currentLocation].storeParentWithPurplelist(previousLocation)
for e in range(len(dictToCrawl[previousLocation].getParents())):
if not dictToCrawl[previousLocation].getParents()[e].isPurple():
break
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if e==len(dictToCrawl[previousLocation].getParents())-1:
dictToCrawl[previousLocation].markPurple()
workingAddress.append(currentLocation)
if not workingAddress in dictToCrawl[currentLocation].listOfAddresses:
workingAddressRes=[]
for e in range(len(workingAddress)):
workingAddressRes.append(genDiffsList[workingAddress[e]][0])
workingAddressResString=""
for e in range(len(workingAddressRes)):
if workingAddressRes[e]=="I/L":
workingAddressResString+="J"
else:
workingAddressResString+=workingAddressRes[e]
dictToCrawl[currentLocation].addAddress(workingAddress)
if len(workingAddress)>=len(genDiffsList)/20:
print(">= #nodes/16: "+str(workingAddress))
print(workingAddressResString)
print("Address at "+str(currentLocation))
arrivedAtTerminus=True
else:
methodOfPathSelection="random"
if methodOfPathSelection=="processive":
noMoreAvailablePaths=False
wrongPathChoice=True
lenOfParents=len(dictToCrawl[currentLocation].getParents())
pathChoice=0
while wrongPathChoice and pathChoice<=lenOfChildren:
if pathChoice==lenOfParents:
keepAlive-=1
noMoreAvailablePaths=True
elif not dictToCrawl[currentLocation].getParents()[pathChoice].isPurple():
wrongPathChoice=False
else:
keepAlive-=1
pathChoice+=1
if noMoreAvailableChoices:
break
elif methodOfPathSelection=="random":
wrongPathChoice=True
while wrongPathChoice==True and keepAlive>0:
keepAlive-=1
pathChoice=random.choice(list(range(len(dictToCrawl[currentLocation].getParents()))))
if not dictToCrawl[pathChoice].isPurple():
wrongPathChoice=False
try:
nextNodeIndex=dictToCrawl[currentLocation].getParents()[pathChoice].value
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except IndexError:
print("IndexError")
print("pathChoice: "+str(pathChoice))
print("currentLocation: "+str(currentLocation))
keepAlive-=10
break
workingAddress.append(currentLocation)
#while not arrivedAtTerminus will have been broken out off if no remaining choices
previousLocation=currentLocation
currentLocation=nextNodeIndex
def newReverseCrawl(startingNodeIndex):
newCrawl(startingNodeIndex,reverseDictOfAllNodes)
'''def newReverseCrawl(startingNodeIndex):
def makePathChoice():
keepAlive1=1000
methodOfPathSelection="random"
#Processive path selection, not implemented
if methodOfPathSelection=="processive":
noMoreAvailablePaths=False
wrongPathChoice=True
lenOfChildren=len(dictOfAllNodes[currentLocation].getChildren())
pathChoice=0
while wrongPathChoice and pathChoice<=lenOfChildren:
if pathChoice==lenOfChildren:
print "pathChoice="+str(pathChoice)
keepAlive1-=1
noMoreAvailablePaths=True
elif not dictOfAllNodes[currentLocation].getChildren()[pathChoice].isBlack():
wrongPathChoice=False
else:
keepAlive1-=1
pathChoice+=1
if noMoreAvailableChoices:
break
elif methodOfPathSelection=="random":
wrongPathChoice=True
while wrongPathChoice==True and keepAlive1>0:
keepAlive1-=1
pathChoice=random.choice(range(len(dictOfAllNodes[currentLocation].getChildren())))
if not dictOfAllNodes[pathChoice].isBlack():
wrongPathChoice=False
return pathChoice
return "He"
keepAlive=len(genDiffsList)*28
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#?
noMoreAvailabeChoices=False
while keepAlive>0 and not noMoreAvailableChoices:
#start making a chain from startingNode
workingAddress=[]
currentLocation=startingNodeIndex
previousLocation=currentLocation
arrivedAtTerminus=False
workingAddress.append(startingNodeIndex)
while not arrivedAtTerminus:
if len(dictOfAllNodes[currentLocation].getChildren())==0:
#end of the chain
if not workingAddress in reverseDictOfAllNodes[currentLocation].listOfAddresses:
workingAddressResString=convertToResidue(workingAddress)
processOutput=processFinishedAddress(workingAddress,workingAddressResString,keepAlive)
keepAlive=processOutput
else:
keepAlive-=1
arrivedAtTerminus=True
else:
pathChosen=makePathChoice()
#I'll come back later'''
def printStrings():
'''Just an idea'''
growingStrand=[]
listOfStrands=[]
#for a in range(10):
#if len(dictOfAllNodes[a].listOfChildren)>0:
def checkfor28difference():
tempKeys=list(dictToCrawl.keys())
lengthOfKeys=len(tempKeys)
for e in range(0,lengthOfKeys):
for f in range(e,lengthOfKeys):
if within18(dictToCrawl[tempKeys[e]],dictToCrawl[tempKeys[f]]):
print(str(tempKeys[e])+", "+str(tempKeys[f]))
def intensityNormalize(inputList):
largestSoFar=0
for element in inputList:
if element>largestSoFar:
largestSoFar=element
mutatedList=[]
for element in inputList:
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mutatedList.append(float(element)/float(largestSoFar))
return mutatedList
inputFile=input("Enter file location (surround with quotation marks, double any backslashes): ")
global setNewTolerance
setNewTolerance=(input("Use 0.35 m/z tolerance (y/n with quotation marks)?"))
readOut=readConfig(str(inputFile))
peakList=readOut[0]
peakList2Unnormalized=readOut[1]
peakList2=intensityNormalize(peakList2Unnormalized)
genDiffs()
createTree()

